NO983402L - Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner - Google Patents

Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner

Info

Publication number
NO983402L
NO983402L NO983402A NO983402A NO983402L NO 983402 L NO983402 L NO 983402L NO 983402 A NO983402 A NO 983402A NO 983402 A NO983402 A NO 983402A NO 983402 L NO983402 L NO 983402L
Authority
NO
Norway
Prior art keywords
nukeoside
analogues
combination therapy
herpes simplex
simplex infections
Prior art date
Application number
NO983402A
Other languages
English (en)
Other versions
NO983402D0 (no
NO316355B1 (no
Inventor
Malcolm Richard Boyd
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983402(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO983402L publication Critical patent/NO983402L/no
Publication of NO983402D0 publication Critical patent/NO983402D0/no
Publication of NO316355B1 publication Critical patent/NO316355B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19983402A 1996-01-26 1998-07-23 Farmas degree ytisk produkt og anvendelse av dette for behandling og forebyggelseav herpes simplex-infeksjoner NO316355B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601544.1A GB9601544D0 (en) 1996-01-26 1996-01-26 Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (en) 1996-01-26 1997-01-24 Nucleoside analogs in combination therapy of herpes simplex infections

Publications (3)

Publication Number Publication Date
NO983402L true NO983402L (no) 1998-07-23
NO983402D0 NO983402D0 (no) 1998-07-23
NO316355B1 NO316355B1 (no) 2004-01-19

Family

ID=10787583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983402A NO316355B1 (no) 1996-01-26 1998-07-23 Farmas degree ytisk produkt og anvendelse av dette for behandling og forebyggelseav herpes simplex-infeksjoner

Country Status (26)

Country Link
US (5) US6514980B1 (no)
EP (1) EP0876146B1 (no)
JP (1) JP2000507211A (no)
KR (1) KR19990081966A (no)
CN (1) CN1133433C (no)
AR (1) AR005551A1 (no)
AT (1) ATE238796T1 (no)
AU (1) AU713202B2 (no)
BR (1) BR9707304A (no)
CY (1) CY2421B1 (no)
CZ (1) CZ297841B6 (no)
DE (1) DE69721484T2 (no)
DK (1) DK0876146T3 (no)
ES (1) ES2199339T3 (no)
GB (1) GB9601544D0 (no)
HK (1) HK1016475A1 (no)
HU (1) HU226793B1 (no)
IL (1) IL125075A (no)
NO (1) NO316355B1 (no)
NZ (1) NZ326839A (no)
PL (1) PL187076B1 (no)
PT (1) PT876146E (no)
TR (1) TR199801439T2 (no)
TW (1) TW493985B (no)
WO (1) WO1997026882A1 (no)
ZA (1) ZA97608B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7591945B2 (en) * 2003-02-07 2009-09-22 Gambro Lundia Ab Support device for containers in extracorporeal blood treatment machines
CA2602562C (en) * 2005-03-25 2015-07-07 Alt Solutions, Inc. Modulation of telomere length in telomerase positive cells and cancer therapy
WO2006125166A2 (en) * 2005-05-18 2006-11-23 Alt Solutions, Inc. Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) * 2019-05-23 2019-07-10 Douglas Pharmaceuticals Ltd Treatment of conditions
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) * 1964-09-03 1967-05-30 Merck & Co Inc Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
ATE146075T1 (de) 1992-10-01 1996-12-15 Wellcome Found Tucaresol als mittel zur immunopotentierung
GB9426021D0 (en) 1994-12-22 1995-02-22 Smithkline Beecham Plc Pharmaceuticals
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections

Also Published As

Publication number Publication date
US20050222016A1 (en) 2005-10-06
ZA97608B (en) 1998-07-24
CN1209748A (zh) 1999-03-03
WO1997026882A1 (en) 1997-07-31
CZ297841B6 (cs) 2007-04-11
CZ234098A3 (cs) 1999-02-17
IL125075A (en) 2003-02-12
NO983402D0 (no) 1998-07-23
BR9707304A (pt) 1999-07-20
PL327917A1 (en) 1999-01-04
EP0876146A1 (en) 1998-11-11
TR199801439T2 (xx) 1998-10-21
PL187076B1 (pl) 2004-05-31
EP0876146B1 (en) 2003-05-02
DK0876146T3 (da) 2003-08-11
DE69721484D1 (de) 2003-06-05
GB9601544D0 (en) 1996-03-27
DE69721484T2 (de) 2004-02-26
HUP9900945A3 (en) 2001-02-28
CY2421B1 (en) 2004-11-12
AU1550697A (en) 1997-08-20
HUP9900945A2 (hu) 1999-07-28
PT876146E (pt) 2003-09-30
US20080287389A1 (en) 2008-11-20
CN1133433C (zh) 2004-01-07
JP2000507211A (ja) 2000-06-13
IL125075A0 (en) 1999-01-26
NO316355B1 (no) 2004-01-19
NZ326839A (en) 2001-02-23
ATE238796T1 (de) 2003-05-15
US6514980B1 (en) 2003-02-04
KR19990081966A (ko) 1999-11-15
AU713202B2 (en) 1999-11-25
AR005551A1 (es) 1999-06-23
US20040185433A1 (en) 2004-09-23
HU226793B1 (en) 2009-10-28
ES2199339T3 (es) 2004-02-16
TW493985B (en) 2002-07-11
HK1016475A1 (en) 1999-11-05
US20100323952A1 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
NO983560D0 (no) Triazolderivater nyttige i terapi
PT769965E (pt) Formulacoes aquosas de risperidona
ZA9710339B (en) Xanthines and their therapeutic use
ID18679A (id) Penggunaan terapi lanjutan
NO982727D0 (no) PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon
FI953127A0 (fi) Puriinijohdannaisia
EE03439B1 (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
NO983402L (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
NO972103L (no) Eleutherobin og analoger av denne
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
ATA96193A (de) Ausziehbare saunakabine
GB9419692D0 (en) Treatment of herpes infections
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
BR9406575A (pt) Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
AU2413597A (en) Addition of accelerators in gunite
AU5206793A (en) Use of CN-substituted benzimidazoles
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
DK98093D0 (da) Herpesmiddel
KR950014092U (ko) 자동차의 전면부 차체구조
KR940018874U (ko) 치질 환자용 의자
KR930020772U (ko) 좌우겸용 신발
ZA964000B (en) Xanthines and their therapeutic use
KR970037669U (ko) 차체의 전방구조
KR970017647U (ko) 차체의 전면구조

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees